Indaptus Therapeutics, Inc.

📍 New York, United States🗓 Founded 2021👥 11 employees💰 Last funded 2021
Biotechnology Research🌐 indaptusrx.com
Website LinkedIn
The Indaptus Goal is Simple: to Cure Disease With the ability to harness both the body’s innate and adaptive immune responses, we believe we are uniquely positioned to revolutionize the treatment of cancer and certain infectious diseases. Building on the observation that tumor regression can occur in the setting of bacterial infection, we have developed a proprietary platform that exploits bacteria’s natural ability to activate both innate and adaptive cellular immune pathways. Leveraging our novel insights into the levels and ratios of activating signals needed to safely elicit a broad immune response, we are creating and advancing a pipeline of proprietary, attenuated and killed non-pathogenic gram-negative bacterial candidates designed to be widely accessible, with broad anti-tumor and anti-viral activity.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Indaptus Therapeutics, Inc.?
Indaptus Therapeutics, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Indaptus Therapeutics, Inc. last raise funding?
The most recent investment in Indaptus Therapeutics, Inc. recorded on gritt.io was in 2021.
When was Indaptus Therapeutics, Inc. founded?
Indaptus Therapeutics, Inc. was founded in 2021.
What industry is Indaptus Therapeutics, Inc. in?
Indaptus Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Indaptus Therapeutics, Inc. based?
Indaptus Therapeutics, Inc. is headquartered in New York, United States.